IX1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - IDEXX Laboratories Inc

Watchlist Manager

Watchlist

Price: 481.4 EUR 0.06% Market Closed

Market Cap: €40B

I	IDEXX Laboratories Inc SWB:IX1	US
A	Amgen Inc HKEX:4332	US
	Elbit Systems Ltd NASDAQ:ESLT	IL
	Vivani Medical Inc F:U5P	US
N	Norwegian Air Shuttle ASA LSE:0FGH	NO

Profitability Summary

IDEXX Laboratories Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

62%

Strong 3Y Average Gross Margin

61%

Gross Margin is Increasing

60% > 62%

Exceptional Operating Margin

32%

Strong 3Y Average Operating Margin

30%

Operating Margin is Increasing

30% > 32%

Healthy Net Margin

25%

Sustainable 3Y Average Net Margin

23%

Net Margin is Increasing

23% > 25%

Exceptional Free Cash Flow Margin

24%

Strong 3Y Average Free Cash Flow Margin

21%

Free Cash Flow Margin is Increasing

17% > 24%

Exceptional ROE

73%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

34%

ROIC is Increasing

33% > 38%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.